Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

NCT00695019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: interferon-alpha lozenges
DRUG: placebo lozenges

Sponsor

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Collaborators

[object Object]